![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma Strategically Advances Its Promising Alzheimer's Drug
March 05, 2007 10:55 ET
|
Samaritan Pharmaceuticals, Inc.
Enters Service Agreement With Advinus Therapeutics, India to Validate
Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol
Strategy is to Bolster Caprospinol Alzheimer's Data...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma Completes Acquisition of Metastatin Pharmaceuticals
March 01, 2007 09:56 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, March 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announced today that the company has closed its acquisition of...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Shire plc Signs Marketing Agreement With Samaritan Pharma
February 26, 2007 10:24 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Feb. 26, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has signed a marketing and distribution agreement,...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma Files Patent to Protect SP-04 as Bioterrorism Nerve Gas Antidote
February 22, 2007 09:53 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Feb. 22, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has filed a patent application to protect SP-04 as a...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma Aims At SP-6300 as New Innovative Treatment for Cushing's Syndrome
February 06, 2007 12:05 ET
|
Samaritan Pharmaceuticals, Inc.
Files New Patent Application for SP-6300 Making Use
of SP-01A's Phase II Study Data
Drug SP-01A (HIV), SP-6300 (Cushing's) Demonstrates a Statistically
...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma Requests Hearing Before AMEX's Listing Qualifications Panel to Appeal Non-Acceptance of Company's Compliance Plan
February 02, 2007 18:01 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Feb. 2, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announces it has requested a hearing before the AMEX's listing qualifications...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma's SP-10 Hip On Hep C
January 25, 2007 12:33 ET
|
Samaritan Pharmaceuticals, Inc.
* National Institutes of Allergy and Infectious Diseases (NIAID)
Finds Significant Antiviral Activity With Entry Inhibitor SP-10
for Hepatitis C Virus (HCV)
* "Oral" Antiviral Entry...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Breath of Life Product In-Licensed to Samaritan Pharma
January 22, 2007 10:54 ET
|
Samaritan Pharmaceuticals, Inc.
* ONY's Neonatal U.S. Approved Drug Infasurf to Treat Respiratory
Distress Syndrome in Premature Infants In-Licensed
* Marketing and Sales Rights Granted for Turkey, Serbia, Bosnia,
...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
Samaritan Pharma In-Licenses Rights to Promote and Sell Six of Molteni's Prescription Drugs for Pain, Drug Addiction and Anesthesia in Greece and Cyprus
January 16, 2007 10:33 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Jan. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that it has signed an exclusive license with Molteni...
![Samaritan Pharmaceuticals Company Logo](/news-release/logo/216057/0/216057.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A06&size=2)
FDA Grants IND to Samaritan's Novel Plaque Clearing Alzheimer's Drug and Requests Additional Information Be Provided Before Starting Its Proposed Phase I Trial
December 07, 2006 10:15 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 7, 2006 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced that the U.S. Food and Drug Administration (FDA) has completed its...